USANA Health Sciences Reports Record Results for Second Quarter 2018; Increases 2018 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
USANA Health Sciences Inc. (USNA) PT Raised to $135 at Pivotal Research Amid 'Blow-Out' Qtr
July 25, 2018 2:17 PM EDTPivotal Research raised its price target on USANA Health Sciences Inc. (NYSE: USNA) to $135.00 (from $100.00) while maintaining a Hold rating following 'blow-out' results and higher guidance.
Analyst Timothy Ramey noted sales were positive in every geography even the perennially-flat Americas & Europe region posted a... More
USANA Health Sciences (USNA) Tops Q2 EPS by 23c, Revenues Beat; Boosts FY18 EPS/Revenues Outlook
July 24, 2018 4:35 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.36, $0.23 better than the analyst estimate of $1.13. Revenue for the quarter came in at $301.5 million versus the consensus estimate of $284.54 million.
Our operating results for the second quarter exceeded our expectations and reflect the momentum we are seeing in most of our regions. This momentum helped us generate the highest quarterly revenue and earnings per share in the Companys history, said Kevin Guest, Chief Executive Officer. Although the... More
